NCT04951505View on ClinicalTrials.gov

Safety and Intrapulmonary Pharmacokinetics of Cefepime and Taniborbactam in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

June 29, 2021

Primary Completion Date

September 27, 2021

Study Completion Date

September 27, 2021

Conditions

Healthy Subjects

Interventions

DRUG

cefepime-taniborbactam

IV infusion

Trial Locations (1)

85032

Pulmonary Associates PA, Phoenix

All Listed Sponsors

lead

Venatorx Pharmaceuticals, Inc.

INDUSTRY